Quantifying Regulatory Bottlenecks in South Korea’s Clinical Trial Approval Process Through an Analytic Hierarchy Process Framework
- 25 September 2026
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 200
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea (2021R1A6A1A03044296)
- Ministry of Food and Drug Safety of South Korea (22183MFDS366)
This publication has 38 references indexed in Scilit:
- Strengthening the Use of International Collaborative Regulatory Assessments and Regulatory Alignment– Implications for Global ConvergenceTherapeutic Innovation & Regulatory Science, 2025
- Changes in Early-Phase Clinical Trials in China During 2013–2022: A ReviewDrugs in R&D, 2024
- Industry Perceptions and Experiences with the Access Consortium New Active Substance Work-Sharing Initiative (NASWSI): Survey Results and RecommendationsTherapeutic Innovation & Regulatory Science, 2024
- Independent Advice on Drug Approvals: an Investigation of EMA PracticesJournal of General Internal Medicine, 2023
- Changes in the Review Period of Drug Application and a Drug Lag from the FDA and the EMA: An Industry Survey in South Korea Between 2011 and 2020Therapeutic Innovation & Regulatory Science, 2022
- Evolving Landscape of New Drug Approval in Japan and Lags from International Birth Dates: Retrospective Regulatory AnalysisClinical Pharmacology & Therapeutics, 2020
- Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation ResearchAdministration and Policy in Mental Health and Mental Health Services Research, 2013
- Consistency prediction for incomplete AHP matricesMathematical and Computer Modelling, 1993
- How to make a decision: The analytic hierarchy processEuropean Journal of Operational Research, 1990
- The analytic hierarchy process—what it is and how it is usedMathematical Modelling, 1987